- Home
- NYXH vs THTX Comparison
NYXH vs THTX Comparison
Compare NYXH & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- THTX
- Stock Information
- Founded
- NYXH 2009
- THTX 1993
- Country
- NYXH Belgium
- THTX Canada
- Employees
- NYXH N/A
- THTX N/A
- Industry
- NYXH Medical/Dental Instruments
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- NYXH Health Care
- THTX Health Care
- Exchange
- NYXH Nasdaq
- THTX Nasdaq
- Market Cap
- NYXH 179.1M
- THTX 144.8M
- IPO Year
- NYXH 2021
- THTX N/A
- Fundamental
- Price
- NYXH $4.78
- THTX $3.31
- Analyst Decision
- NYXH Strong Buy
- THTX Hold
- Analyst Count
- NYXH 3
- THTX 1
- Target Price
- NYXH $15.00
- THTX N/A
- AVG Volume (30 Days)
- NYXH 60.4K
- THTX 530.3K
- Earning Date
- NYXH 11-05-2025
- THTX 10-09-2025
- Dividend Yield
- NYXH N/A
- THTX N/A
- EPS Growth
- NYXH N/A
- THTX N/A
- EPS
- NYXH N/A
- THTX N/A
- Revenue
- NYXH $5,793,306.00
- THTX $84,378,000.00
- Revenue This Year
- NYXH $118.20
- THTX N/A
- Revenue Next Year
- NYXH $278.04
- THTX $13.76
- P/E Ratio
- NYXH N/A
- THTX N/A
- Revenue Growth
- NYXH 2.94
- THTX 2.19
- 52 Week Low
- NYXH $4.56
- THTX $1.12
- 52 Week High
- NYXH $11.87
- THTX $3.34
- Technical
- Relative Strength Index (RSI)
- NYXH 26.11
- THTX 74.01
- Support Level
- NYXH $4.56
- THTX $3.26
- Resistance Level
- NYXH $6.09
- THTX $3.34
- Average True Range (ATR)
- NYXH 0.26
- THTX 0.02
- MACD
- NYXH -0.08
- THTX -0.00
- Stochastic Oscillator
- NYXH 12.22
- THTX 70.00
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.